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ABSTRACT 
Aim: The research was primarily set to assess the stages at which acute kidney injuries 
(AKI) are presented for clinical appraisal.  
Methods: The research was carried out in southwest Nigeria. A total of 151 participants 
were included, 101 were AKI patients. The remaining 50 were apparently healthy 
individuals who had no history of AKI, who served as control. Estimation of plasma 
creatinine was carried out on the subjects’ blood sample. Values were then subjected to 
statistical analysis using SPSS 17. The diagnosis and staging of AKI was based on 
history taken and a rise in plasma creatinine to set cut off points. AKI patients were 
therefore grouped into three with respect to the plasma creatinine content of the first 
blood sample collected on presentation. The three stages were titled 1, 2, and 3; 1 and 3 
being mild and severe respectively.  
Result: A significant rise in plasma creatinine was observed when the AKI patients were 
compared with control. The frequencies of patients at each AKI stage were 17, 5, and 79 
for stages 1, 2, and 3 respectively. The age groups and frequency of AKI were: up to 10 
years (31), 11 to 20years (6), 21 to 30 years (27), 31 to 4 years (33), 41 to 50 years (4), 
51 to 60 years (5), and 60 years and above (6).  
Conclusion: It appears that in the absence of metabolic diseases, the frequency of AKI is 
higher in children and between the age group of 21 to 40.  
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INTRODUCTION 
The kidney is a vital organ. In order for the 
human system to function normally and for man 
to be relatively healthy, an inner chemical 
balance is necessary. This balance is primarily 
regulated by a pair of kidneys. The kidney clears 
the body wastes and maintains homeostasis with 
respect to water, electrolytes and pH (Bolarin, 
2010). Summarily, the kidney can be said to 
perform three important functions. The first is 
the excretion of waste products and the 
preservation of essential solutes (Heusel et al., 
1999). The second function is the regulation of 
water (Reeves et al., 1996; Maunsback et al., 
1996), acid-base (Vanholder et al., 1995) and, 
electrolyte homeostasis (Newman and Price, 
1999).The third is the endocrine function (Fine 
et al., 1991; Brown et al., 1992; Jelkman, 
1992).The functional unit of the kidney is the 
nephron.The optimal functioning of the kidney 
requires an adequate number of structurally and 
functionally intact nephrons (Whitby et al., 
1989). Kidney injury is said to occur when the 
kidneys are unable to perform their functions 
efficiently. Kidney injury could be acute or 
chronic. Whitby et al., (1989) defined acute 
kidney injury (AKI) as a renal disease of acute 
onset, but severe enough to cause failure of 
kidney function. In practice, acute kidney injury 
is diagnosed using the estimation of plasma 
creatinine levels but according to the Kidney 
Disease: Improving Global Outcomes (KDIGO) 
work group, the diagnosis and grading of acute 
kidney injury is based on either plasma 
creatinine level or the estimation of urine 
output. In this  research, the use of plasma 
creatinine level is the assessment method of 
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choice since the assessment based on urine 
output in these patients is somehow severe and 
cumbersome (Leung  et al., 2013). Stated below 
are the peculiarities of the KDIGO RIFLE 
classification method (Bellomo et al., 2013). 
The risk stage is diagnosed upon the finding of 
one of the following (i) a 1.5 fold increase in 
serum creatinine level,(ii)  a more than 25% 
decrease in GFR or (iii) a urine output less than 
0.5 ml/kg per h for 6 h. The Injury stage is 
diagnosed upon the finding of at least one of the 
following:(i) a two fold increase in serum 
creatinine level,(ii) a greater than 50% decrease 
in GFR or (iii) a urine output less than 0.5 ml/kg 
per hour for 12 hours. The third (failure) stage is 
diagnosed upon  the finding of   a threefold 
increase in serum creatinine level, or a 
75%decrease in GFR, or an increase in serum 
creatinine level  ≥4 mg/dl (≥354 µmol/l) with  
an acute plasma creatinine increase ≥0.5 mg/dl 
(≥44 µmol/l) or,   Anuria for 12 hours. The Loss 
stage is diagnosed on the finding of a Persistent 
AKI with complete loss of renal function for 
more than four weeks. End-stage renal disease is 
diagnosed when AKI persists with complete loss 
of renal function for more than 3 months. As 
there is an increase in hospital attendance due to 
kidney related  clinical conditions (Akpa et al.,   
2013), this  research  is  designed to look at how 
early  acute  kidney  injury cases are presented 
to the hospitals and, also to discuss the factors 
responsible for its development and progression 
through a toxicological point of view.  
MATERIALS AND METHODS 
Sources of samples  
A total of 101 samples were collected from 
acute kidney injury (AKI) patients. Blood 
samples were collected upon the patients’ first 
presentation in the hospital.  
 
Inclusion and exclusion criteria  
All subjects in this study were those who 
according to histor, developed the classical signs 
of AKI for not more than 3 months. All patients 
with history of hypertension and diabetes 
mellitus were excluded. All participants in this 
survey were therefore subjects known not be 
patients of metabolic diseases.  
 
Determination of plasma creatinine was done 
using the Jaffe (1886) reaction based kinetic 
method as explained by Vaishya et al., (2010)
  
Determination of baseline plasma creatinine 
level. The mean plasma creatinine level of 
control subjects in this investigation was taken 
as the baseline plasma creatinine level. Stage 1 
(Risk) <184 µmol/L; Stage 2 (Injury) ≥184 
µmol/L but<276 µmol/L; Stage 3 (Failure, Loss 
of function and ESRD) >276µmol/L 
RESULTS 
Table 1. The  mean, standard deviation (SD), 
Student’s t when the creatinine levels of AKI 
patients were compared with the control 
 Mean 
(µmol/L) 
SD 
(µmol/L) 
Student’s 
t 
Remarks 
AKI 869 691 8.0 Significant 
Control 92 12   
 
Table 2.  Frequency of each AKI stage 
Stage 1(Risk) 2(Injury) 3(Failure to ESRD) 
Frequency 17 5 79 
 
 
 
Fig 1 Distribution of AKI according to age 
 
DISCUSSION 
Plasma creatinine is a classical analyte used in 
the assessment of renal function (Burtis and 
Ashwood, 1999). It increases in plasma 
following renal injury. A significant variation 
was observed when the mean creatinine levels 
of AKI patients were compared with that of 
control (Table 1). There was also a significant 
variation when the mean creatinine levels of 
control were compared with that of Stages 1, 2, 
and 3 respectively.  Table 2 shows a pattern of 
late presentation of AKI cases for clinical 
appraisal. Humans are exposed to a variety of 
potential nephrotoxic substances on a rather 
frequent basis (Guyton and Arthur, 1991; Isnard 
et al., 2004; Parazella, 2005; Schetz et al., 
2005). Several therapeutic agents have known 
nephrotoxic potentials; classical examples 
include anti-microbial agents (Rougier et al, 
2003, Izzedine et al., 2001), chemotherapeutic 
agents (Kintzel PE, 2001; Lamierre et al., 2005), 
analgesics (Elsevier and Debroe, 1999), and 
immunosuppressive agents (Gambaro et al., 
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2003). Some of these drugs are prescription 
drugs while majority are over-the-counter drugs. 
A similar point is that Nigerians believe in the 
efficacy of alternative/complimentary therapy, 
herbal concoctions, infusions and mixes, maybe 
because it is most often relatively cheap, and 
more accessible. Moreover, Africans are faced 
with the menace of exorbitant cost of ―western 
drugs‖.  Though it is not the duty of the 
investigators in this research to doubt the 
efficacy of alternative therapy, we stress that 
more harm than good may be done if wrong 
diagnoses are made, or if the treatment is 
ineffective. A worst case scenario would be a 
situation in which one or more ingredients of the 
therapy are potential nephrotoxic 
phytochemicals. Similar circumstances are cases 
of product preservation and adulteration or 
substitution of a key ingredient (Isnard et al., 
2004; Blowey, 2005), most probably to 
maximize profits. An increasing nephrotoxic 
concern is lead exposure, even at levels that are 
considered safe and acceptable to governmental 
agencies (Navas-acien et al., 2004). Other 
peculiarities and patterns could be unraveled if a 
critical look is taken at Fig I. The age brackets 
of up to 10, 21 – 30, and 31 -40 are the highest 
sufferers of AKI and the points are not 
farfetched, Parental carelessness and negligence 
or exacerbated susceptibility to AKI will likely 
be the reasons for the age bracket of 10 years 
and below, since this age range will solely 
depend on parental guidance and judgment. 
From a different perspective, the reason for an 
upsurge in AKI in the 21 – 40 years group could 
be due to the effect of self medication, riotous 
lifestyles, youthful exuberance, and 
indiscriminate use of performance enhancing or 
club drugs (Blowey, 2005). Recreational drugs 
and their metabolites have been known to have 
adverse effects on the kidney, some of them 
being chronic and irreversible but occasionally 
acute and reversible (Crowe et al., 2001).  This 
observed trend disagrees with the work of 
Lewington and Kanagasundaram (2011), where 
AKI predominates in the elderly. This may be 
due to the fact that patients known to be 
suffering from hypertension and other diseases 
of the elderly that could have adverse effects on 
the kidney were excluded. The nephron dose of 
an individual is the number of nephrons an 
individual is born with, and it has been 
calculated to be in the range of 400000 to 
800000 (Nyengard and Beenstein, 1992). The 
nephron dose has been proposed to be a 
determinant in the susceptibility of the 
individual to renal injury (Newman and price, 
1999). If a nephron is lost, it can never be 
replaced. Since the functional unit of the kidney 
(The nephrons) is not regenerative in nature 
(Newman and price, 1999). The reason for the 
kidney being easily challenged or injured is not 
farfetched: The susceptibility of renal tissues to 
the toxic effects of potentially harmful 
chemicals can be attributed in part to the 
peculiarities in the anatomic and physiologic 
features of this organ. For instance, under 
resting state, the renal tissue receives about 20-
25% of the resting cardiac output (Raina and 
Hamid, 2013). Therefore, any drug or chemical 
in the systemic circulation will be delivered to 
this organ in relatively high amounts; 
consequently, non-toxic concentrations of a 
chemical in the plasma or other tissues may 
reach toxic concentration in the kidney (Raina 
and Hamid, 2013).  
CONCLUSION 
It appears that in the absence of metabolic 
diseases and diseases of the elderly such as 
hypertension and diabetes mellitus, the 
frequency of AKI is higher in children and 
between the age group of 21 to 40.  
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